These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 773950)

  • 1. Effects of somatostatin on basal levels of plasma growth hormone and insulin in acromegalics: dose-response studies and attempted total growth hormone suppression.
    Christensen SE; Nerup J; Hansen AP; Lundbaek K
    J Clin Endocrinol Metab; 1976 May; 42(5):839-45. PubMed ID: 773950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response study of the inhibiting effect of somatostatin on growth hormone and insulin secretion in normal subjects and acromegalic patients.
    Giustina G; Peracchi M; Reschini E; Panerai E; Pinto M
    Metabolism; 1975 Jul; 24(7):807-15. PubMed ID: 1138156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The somatostatin analogue SMS 201-995 in acromegaly: prolonged, preferential suppression of growth hormone but not pancreatic hormones.
    George SR; Hegele RA; Burrow GN
    Clin Invest Med; 1987 Jul; 10(4):309-15. PubMed ID: 2888554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the somatostatin analog D-Trp8,D-Cys14 on glucose insulin, pancreatic glucagon and growth hormone plasma levels in acromegalics and mild diabetics.
    Trovati M; Massara F; Camanni F; Molinatti GM; Lorenzati R; Pagano GF
    J Endocrinol Invest; 1980; 3(2):189-92. PubMed ID: 6104680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The response of pancreatic and pituitary hormones to pulses and constant infusion of somatostatin.
    Leblanc H; Rigg LA; Yen SS
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1105-9. PubMed ID: 1206096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of somatostatin on plasma insulin and growth hormone levels in basal conditions and after glucagon in normal and acromegalic subjects.
    Massara F; Porzio G; Camanni F; Molinatti GM
    Acta Diabetol Lat; 1975; 12(3-4):219-31. PubMed ID: 1224905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effect of levodopa and somatostatin on the plasma levels of growth hormone, insulin, glucagon and prolactin in acromegaly.
    Dunn PJ; Donald RA; Espiner EA
    Clin Endocrinol (Oxf); 1976 Mar; 5(2):167-74. PubMed ID: 1269163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intracerebroventricular infusion of somatostatin-14 on peripheral glucoregulation in dogs.
    Yavropoulou MP; Kotsa K; Pikilidou M; Keisisoglou I; Yovos JG
    J Neuroendocrinol; 2014 Jan; 26(1):11-7. PubMed ID: 24325321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients.
    Wajchenberg BL; Cesar FP; Leme CE; Borghi VC; Souza VC; Souza IT; Neto DG; Germek OA; Coy DH; Comaru-Schally AM
    Horm Metab Res; 1983 Oct; 15(10):471-4. PubMed ID: 6139329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients.
    Lamberts SW; Oosterom R; Neufeld M; del Pozo E
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1161-5. PubMed ID: 2860119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of somatostatin of plasma levels of glucose, insulin and growth hormone in acromegaly].
    Porzio G; Massara F; Camanni F; Rizzi G; Molinatti GM
    Minerva Med; 1976 Oct; 67(50):3241-2. PubMed ID: 995281
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth hormone secretion and pancreatic function following somatostatin infusion in ducks (Anas platyrhynchos).
    Strosser MT; Harvey S; Foltzer C; Mialhe P
    Br Poult Sci; 1985 Jul; 26(3):425-32. PubMed ID: 2862973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly.
    Kelijman M; Williams TC; Downs TR; Frohman LA
    J Clin Endocrinol Metab; 1988 Nov; 67(5):958-63. PubMed ID: 2903171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone-releasing hormone infusion in patients with active acromegaly.
    Losa M; Chiodini PG; Liuzzi A; König A; Müller OA; Schopohl J; von Werder K
    J Clin Endocrinol Metab; 1986 Jul; 63(1):88-93. PubMed ID: 3086362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary and extrapituitary effects of somatostatin in normal man.
    Copinschi G; Leclercq-Meyer V; Virasoro E; L'Hermite M; Vanhaelst L; Golstein J; Leclercq R; Féry F; Robyn C
    Horm Metab Res; 1976 May; 8(3):226-31. PubMed ID: 181309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
    Yen SS; Siler TM; DeVane GW
    N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
    [No Abstract]   [Full Text] [Related]  

  • 19. Abuse of recombinant human growth hormone: studies in two different dog models.
    Rigamonti AE; Scanniffio D; Bonomo SM; Cella SG; Sartorio A; Müller EE
    Neuroendocrinology; 2004; 79(5):237-46. PubMed ID: 15218318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-stimulated insulin response in pregnant sheep following acute suppression of plasma non-esterified fatty acid concentrations.
    Regnault TR; Oddy HV; Nancarrow C; Sriskandarajah N; Scaramuzzi RJ
    Reprod Biol Endocrinol; 2004 Sep; 2():64. PubMed ID: 15352999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.